Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
117.64
-6.20 (-5.01%)
Aug 20, 2026, 1:48 PM EDT - Market open
Monopar Therapeutics Employees
Monopar Therapeutics had 22 employees as of December 31, 2025. The number of employees increased by 6 or 37.50% compared to the previous year.
Employees
22
Change (1Y)
6
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$811,125
Market Cap
789.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | 6 | 37.50% | 22 | 0 |
| Dec 31, 2024 | 16 | 6 | 60.00% | 14 | 2 |
| Dec 31, 2023 | 10 | -2 | -16.67% | 9 | 1 |
| Dec 31, 2022 | 12 | 2 | 20.00% | 11 | 1 |
| Dec 31, 2021 | 10 | 0 | - | 9 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| REGENXBIO | 371 |
| Rigel Pharmaceuticals | 174 |
| DBV Technologies | 170 |
| Neurogene | 131 |
| Aura Biosciences | 113 |
| Silence Therapeutics | 88 |
| Oculis Holding AG | 60 |
MNPR News
- 1 day ago - Monopar Appoints Jeffrey D. Kent, M.D. - GlobeNewsWire
- 3 days ago - Monopar Therapeutics price target raised to $130 from $115 at Morgan Stanley - TheFly
- 3 days ago - Monopar Therapeutics reports Q2 EPS (62c), consensus (65c) - TheFly
- 3 days ago - Monopar Therapeutics sees cash runway through December 31, 2027 - TheFly
- 3 days ago - Monopar Therapeutics price target raised to $133 from $117 at BTIG - TheFly
- 3 days ago - Monopar Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald - TheFly
- 3 days ago - Monopar Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald - TheFly
- 3 days ago - Monopar Therapeutics price target raised to $128 from $125 at Barclays - TheFly